New UK Vision Strategy launched

Article

The refreshed UK Vision Strategy was launched at the Vision UK 2013 Conference, according to a press statement.

The refreshed UK Vision Strategy was launched at the Vision UK 2013 Conference.

The strategy, held at the QE2 Centre, London, UK, contains all the aims of the original 2008 strategy but has undergone significant development. Three new key outcomes of the measure were announced including the encouragement of the UK population to maintain their eyesight, guaranteeing primary treatment for those with existing eye conditions and ensuring those with sight loss can fully participate in society.

Don Grocott, Optical Confederation Chairman, commented, “Much has been achieved under the original UK Vision Strategy, not least the Eye Health Indicator in England and the considerable work to improve eye health, prevent visual impairment and enable people with sight loss to lead active, full and inclusive lives in all four UK countries.”

“However, there is much more to do and people in this country, especially older people and people from minority groups, are still losing their sight at rates which are just not acceptable,” continued Mr Grocott. “As founder members of the UK Vision Strategy and enthusiastic supporters of Vision 2020 UK, the Optical Confederation and its members will continue to strive to improve eye health for all and offer access to the highest quality community eye health services and vision correction.”

David Hewlett, representing the Optical Confederation at the conference, stated, “Continuing emphasis on the importance of looking after your eyes and regular sight testing is very welcome. This is the best means of achieving eye health for all and reducing the unacceptable levels of avoidable sight loss in the UK.”

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.